Korea Bizwire, Author at Be Korea-savvy | Page 39 of 385
North Korea Vows ‘Toughest’ Military Actions as U.S. Sends Aircraft Carrier

North Korea Vows ‘Toughest’ Military Actions as U.S. Sends Aircraft Carrier

SEOUL, April 11 (Korea Bizwire) – North Korea vowed Tuesday to take the “toughest” counteraction against the United States as Washington is sending its strategic assets near the Korean Peninsula for what the North calls an invasion of Pyongyang. The North’s warning was made after the U.S. dispatched the USS Carl Vinson, a nuclear-powered aircraft [...]

Cigarettes Contain 7 Human Carcinogens

Cigarettes Contain 7 Human Carcinogens

SEOUL, April 11 (Korea Bizwire) – Cigarettes sold on the market contain seven “cancer-causing” substances that pose a threat to public health, South Korean authorities said Tuesday. The International Agency For Research On Cancer (IARC) under the World Health Organization classifies certain substances as group 1 that are carcinogenic to humans. Substances are placed in [...]

Preorders for Galaxy S8 Skyrocket

Preorders for Galaxy S8 Skyrocket

SEOUL, April 10 (Korea Bizwire) – Some 550,000 South Koreans had placed preorders for the Galaxy S8 and S8+ just two days after the process began on April 7. That is almost three times the number for the Galaxy Note 7 (roughly 200,000 from August 6 to 7) and more than fivefold for the Galaxy [...]

South Korea Sees Widening Wealth Gap Between Leadership Class and Average Households

South Korea Sees Widening Wealth Gap Between Leadership Class and Average Households

SEJONG, April 10 (Korea Bizwire) – The average wealth of South Korea’s leadership class – public officials, lawmakers, and high-ranking judges – was almost six times higher than members of the general public, recent data showed. According to Sunday’s asset disclosures released by the Government Public Ethics Committee, the Supreme Court of Korea and the [...]

“Miracle Cancer Drug” Gleevec Sales Threatened Following Novartis Rebate Scandal

“Miracle Cancer Drug” Gleevec Sales Threatened Following Novartis Rebate Scandal

SEOUL, April 10 (Korea Bizwire) – South Korea’s health authorities are considering a suspension of health insurance reimbursement for imatinib, a highly effective leukemia drug sold under the brand name of Gleevec (or Glivec), after its maker Novartis was found to have provided illegal kickbacks to doctors.  The Swiss multinational pharmaceutical company was investigated by prosecutors [...]